Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an

Christian Juhl Terkelsen1, Jens Flensted Lassen, Bjarne Linde Nørgaard

  • 1Department of Cardiology, Skejby University Hospital, DK-8200 Aarhus N, Denmark. christian_juhl_terkelsen@hotmail.com

European Heart Journal
|December 24, 2004
PubMed

Insights

This study found that ST-elevation myocardial infarction (STEMI) has a better prognosis in unselected patients. Mortality for acute myocardial infarction (AMI) categories was higher than previously reported, with STEMI showing the most favorable outcome.

Area of Science:

  • Cardiology
  • Clinical Research
  • Public Health

Background:

  • Acute myocardial infarction (AMI) classification impacts prognosis.
  • Existing data often comes from biased registries or trials.
  • Prognostic significance in unselected populations needs further evaluation.

Purpose of the Study:

  • To assess the prognostic significance of AMI categories in an unselected cohort.
  • To compare mortality rates across non-STEMI, STEMI, and BBBMI.
  • To validate findings against existing registry data.

Main Methods:

  • Historical cohort study design.
  • Review of patient records from a defined geographical area (1999-2001).
  • Adherence to European Society of Cardiology criteria for AMI diagnosis.

Main Results:

  • 654 AMI patients identified; 54% non-STEMI, 39% STEMI, 6% BBBMI.
  • One-year mortality rates: 31% (non-STEMI), 21% (STEMI), 55% (BBBMI).
  • STEMI demonstrated a significantly more favorable outcome in multivariable analysis (P=0.044).

Conclusions:

  • Mortality in unselected AMI patients exceeds prior estimates.
  • ST-elevation myocardial infarction (STEMI) is associated with the best prognosis.
  • Findings highlight potential biases in registry-based outcome data.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...